BCLC Stage C Hepatocellular Carcinoma — Trials

BCLC Stage C Hepatocellular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06172205	Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC	recruiting	Phase 3	262	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER	1	Dec 3, 2025	clinicaltrials

Data updated 22 days agoSource updated Dec 3, 2025source: clinicaltrials